Reduction in Osteoarthritis Risk After Treatment With Ticagrelor Compared to Clopidogrel: A Propensity Score-Matching Analysis.
Matthew C BakerYingjie WengWilliam H RobinsonNeera AhujaNidhi RohatgiPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2020)
Treatment with ticagrelor was associated with a 29% lower risk of developing OA compared to treatment with clopidogrel over 5 years of follow-up. We hypothesize that the reduction in OA seen in patients who received ticagrelor may in part be due to increased extracellular adenosine levels.